Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that nine ...
Juniper Biosciences, a cutting-edge radiopharmaceutical drug development company, today announced the launch of its Scientific Advisory Board (SAB) and the appointment of Jason S. Lewis, Ph.D., as its ...
Lantheus completes acquisition of Life Molecular Imaging, appoints Dr. Ludger Dinkelborg as Head of R&D, enhancing Alzheimer's diagnostics. Lantheus Holdings, Inc. has completed its acquisition of ...
Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall invasive cancer detection while modestly increasing the recall rate ...
New MRI technique simultaneously maps multiple structural, physiological and molecular biomarkers to characterize brain ...
Spatial-biology tools are collecting more comprehensive data, and companies that want to model cells in silico are hoovering ...
LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the launch of the HCR™ Gold and HCR™ Pro product lines. These offerings ...
Medical imaging routinely used in cancer care may hold far more biological information than previously thought.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results